Career Opportunities in the Foresite Capital Network

About Voyager Therapeutics

Voyager Therapeutics, Inc. (Nasdaq: VYGR) is a biotechnology company dedicated to leveraging the power of human genetics to modify the course of – and ultimately cure – neurological diseases. Our pipeline includes programs for Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and multiple other diseases of the central nervous system. Many of our programs are derived from our TRACER™ AAV capsid discovery platform, which we have used to generate novel capsids and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous dosing. Some of our programs are wholly owned, and some are advancing with partners including Alexion, AstraZeneca Rare Disease; Novartis Pharma AG; Neurocrine Biosciences, Inc.; and Sangamo Therapeutics, Inc. For more information, visit www.voyagertherapeutics.com.

Voyager Therapeutics® is a registered trademark, and TRACER™ is a trademark, of Voyager Therapeutics, Inc.

Job Summary

Voyager Therapeutics, a leader in AAV delivery technology, is expanding our strategic focus on non-viral delivery to further enhance our position as pioneers in neurogenetic medicine. We are seeking a Vice President of Non-Viral Delivery with deep expertise in developing technologies for delivering therapeutics across the blood-brain barrier, including biologics and oligonucleotide-based therapeutics to complement our existing platform technologies. The VP, Non-Viral Delivery will be responsible for developing and implementing a strategic agenda and roadmap to develop Voyager’s non-viral neurotherapeutics technologies.

Responsibilities

• Establish and lead the non-viral delivery roadmap including technology and platform development and optimization, targets and non-clinical strategy
• Provide exemplary scientific leadership for the company's non-viral delivery research programs
• Recruit, motivate, and develop a world-class non-viral delivery team
• Manage oligonucleotide transport activities in discovery research and drive innovation in non-viral blood brain barrier penetrant design
• Support the protection, creation, and expansion of the company's intellectual property
• Participate in the selection, prioritization, and acceleration of asset development
• Leverage technical opportunities and talent for business advantage and innovation initiatives
• Play a major role in business development by recommending key initiatives, plans, collaborations, and potential partnerships
• Present to the company's Board of Directors, Scientific Advisory Board, external stakeholders, and the investment community

Requirements

• Strong scientific leadership and ability to articulate and implement a strategic vision for non-viral delivery
• Extensive people leadership with evidence of team development
• Deep experience in developing nucleic acid based therapeutics required
• Previous work in CNS delivery strongly preferred
• Ability to build and maintain collaborations with industry and academic partners
• Expertise in intellectual property protection and expansion
• Experience in selecting and prioritizing assets for development
• Strong communication and presentation skills, including the ability to present to board members, scientific advisory boards, and external stakeholders
• Familiarity with in vitro and/or in vivo screening methods
• Strong collaboration and stakeholder management skills
• Highly motivated and entrepreneurial biotech environment
• Broad responsibilities and opportunities within a fast-paced, matrix-focused culture
• Ability to deliver on corporate goals
• Intellectual and scientific curiosity
• Scientific rigor and creativity
• Commitment to patient-centricity, transparency, and ethical research values
• Excellence in drug discovery/translational skills
• Enthusiasm for operating within an entrepreneurial and science-driven company environment
• Sophisticated scientific management skills